WuXi AppTec (OTCMKTS:WUXAY) Reaches New 12-Month High – What’s Next?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) shares hit a new 52-week high during trading on Thursday . The stock traded as high as $18.59 and last traded at $18.59, with a volume of 206 shares traded. The stock had previously closed at $17.91.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, WuXi AppTec presently has a consensus rating of “Moderate Buy”.

WuXi AppTec Trading Up 3.8%

The company’s 50-day moving average is $16.45 and its 200-day moving average is $15.07.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings data on Monday, April 27th. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.05. The company had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.59 billion.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.